Efficacy of Ozurdex implant in recalcitrant diabetic macular edema—a single-center experience

International Ophthalmology

Volumn 36, Issue 2, 2016, Pages 207-216

  Bansal, Pooja ^a   Gupta, Vishali ^a   Gupta, Amod ^a   Dogra, Mangat Ram ^a   Ram, Jagat ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Bevacizumab; Dexamethasone intravitreal implant; Ozurdex; Recalcitrant diabetic macular edema; Triamcinolone

Indexed keywords

ANTIGLAUCOMA AGENT; BEVACIZUMAB; DEXAMETHASONE; TRIAMCINOLONE ACETONIDE; ANTIINFLAMMATORY AGENT; DRUG IMPLANT;

ADULT; AGED; ARTICLE; CATARACT; CONJUNCTIVAL HEMORRHAGE; DIABETIC MACULAR EDEMA; DISEASE DURATION; DRUG EFFICACY; DRUG IMPLANT; FEMALE; HUMAN; INJECTION SITE REACTION; INTERVENTION STUDY; INTRAOCULAR PRESSURE; INTRAOCULAR PRESSURE ABNORMALITY; LASER COAGULATION; LENS IMPLANTATION; MAJOR CLINICAL STUDY; MALE; OFF LABEL DRUG USE; PHACOEMULSIFICATION; RETINA MACULA LUTEA; RETROSPECTIVE STUDY; TREATMENT OUTCOME; VISUAL ACUITY; INTRAVITREAL DRUG ADMINISTRATION; MACULAR EDEMA; MIDDLE AGED; PHYSIOLOGY;

ADULT; AGED; ANTI-INFLAMMATORY AGENTS; DEXAMETHASONE; DRUG IMPLANTS; FEMALE; HUMANS; INTRAOCULAR PRESSURE; INTRAVITREAL INJECTIONS; MACULAR EDEMA; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; VISUAL ACUITY;

EID: 84938630315     PISSN: 01655701     EISSN: 15732630     Source Type: Journal    
DOI: 10.1007/s10792-015-0103-5     Document Type: Article

References (33)

1. Bhagat N, Grigorian RA, Tutela A, Zarbin MA (2009) Diabetic macular edema: pathogenesis and management. Surv Ophthalmol 54:1–32
2. Early treatment diabetic retinopathy study research group: photocoagulation for diabetic macular edema: early treatment diabetic retinopathy study report no 1. Arch Ophthalmol 1985;103:1796–1806
3. Schatz H, Madeira D, McDonald HR, Johnson RN (1991) Progressive enlargement of laser scars following grid laser photocoagulation for diffuse diabetic macular edema. Arch Ophthalmol 109:1549–1551
4. Funatsu H, Noma H, Mimura T, Eguchi S, Hori S (2009) Association of vitreous Inflammatory factors with diabetic macular edema. Ophthalmology 116:73–79
5. Karim R, Tang B (2010) Use of antivascular endothelial growth factor for diabetic macular edema. Clin Ophthalmol 4:493–517
6. Intravitreal steroids for macular edema: the past, the present, and the future. Surv Ophthalmol 2008;53:139–149
7. Gillies MC, Islam FM, Zhu M, Larsson J, Wong TY (2007) Efficacy and safety of multiple intravitreal triamcinolone injections for refractory diabetic macular edema. Br J Ophthalmol 91:1323–1326
8. Jonas JB, Kreissig I, Sofker A, Degenring RF (2003) Intravitreal injection of triamcinolone for diffuse diabetic macular edema. Arch Ophthalmol 121:57–61
9. Sutter FKP, Simpson JM, Gillies MC (2004) Intravitreal triamcinolone for diabetic macular edema that persists after laser treatment: three-month efficacy and safety results of a prospective, randomized, double-masked, placebo-controlled clinical trial. Ophthalmology 111:2044–2049
10. Gillies MC, Sutter FK, Simpson JM, Larsson J, Ali H, Zhu M (2006) Intravitreal triamcinolone for refractory diabetic macular edema: two-year results of a doublemasked, placebo-controlled, randomized clinical trial. Ophthalmology 113:1533–1538
11. Martidis A, Duker JS, Greenberg PB, Rogers AH, Puliafito CA, Reichel E (2002) Intravitreal triamcinolone for refractory diabetic macular edema. Ophthalmology 109:920–927
12. Aiello LP, Beck RW, Bressler NM, Browning DJ, Chalam KV, Davis M et al (2011) Rationale for the diabetic retinopathy for the diabetic retinopathy clinical research network treatment protocol for center-involved diabetic macular edema. Diabetic Retinopathy Clinical Research Network; Writing Committee. Ophthalmology 118:5–14
13. Beck RW, Edwards AR, Aiello LP, Bressler NM, Ferris F, Glassman AR et al (2009) Diabetic retinopathy clinical research network (DRCR.net),: three-year follow-up of a randomized trial comparing focal/grid photocoagulation and intravitreal triamcinolone for diabetic macular edema. Arch Ophthalmol 127:245–251
14. Vanrell RH, Cardillo JA, Kuppermann BD (2011) Clinical applications of the sustained-release dexamethasone implant for treatment of macular edema. Clin Ophthalmol 5:139–146
15. Kupperman BD, Blumenkranz MS, Haller JA et al (2007) Dexamethasone DDS Phase II Study Group. Randomized controlled study of an intravitreal dexamethasone drug delivery system in patients with persistent macular edema. Arch Ophthalmol 125:309–317
16. Haller JA, Dugel P, Weinberg DV, Chou C, Whitcup SM (2009) Evaluation of the safety and performance of an applicator for a novel intravitreal dexamethasone drug delivery system for the treatment of macular edema. Retina 29:46–51
17. Haller JA, Kuppermann BD, Blumenkranz MS, Williams GA, Weinberg DV, Chou C et al (2010) Dexamethasone DDS Phase II Study Group: randomized controlled trial of an intravitreal dexamethasone drug delivery system in patients with diabetic macular edema. Arch Ophthalmol 128:289–296
18. Boyer DS, Faber D, Gupta S, Patel SS, Tabandeh H, Li XY et al (2011) Ozurdex Champlain study group: dexamethasone intravitreal implant for treatment of diabetic macular edema in vitrectomized patients. Retina 5:915–923
19. Zucchiatti I, Lattanzio R, Querques G, Turco C, Cascavilla M, Bandello F et al (2012) Intravitreal dexamethasone implant in patients with persistent diabetic macular edema. Ophthalmologica 228:117–122
20. ®) in treatment of recalcitrant diabetic macular edema: a case series. Oman J Ophthalmol 5:79–82
21. Callanan D, Gupta S, Boyer D, Ciulla T, Singer M, Kuppermann B et al (2013) Dexamethasone intravitreal implant in combination with laser photocoagulation for the treatment of diffuse diabetic macular edema. Ophthalmology 120:1843–1851
22. Staurenghi Giovanni, Sadda Srinivas, Chakravarthy Usha, Spaide Richard F (2014) Proposed lexicon for anatomic landmarks in normal posterior segment spectral- domain optical coherence tomography. Ophthalmology 121:1572–1578
23. Sakamoto A, Hangai M, Yoshimura N (2008) Spectral domain optical coherence tomography with multiple B-scan averaging for enhanced imaging of retinal diseases. Ophthalmology 115:1071–1078
24. Puliafito CA, Hee MR, Lin CP, Rechiel E, Schuman JS, Duker JS et al (1995) Imaging of macular diseases with optical coherence tomography. Ophthalmology 102:217–229
25. Otani T, Yamaguchi Y, Kishi S (2010) Correlation between visual acuity and foveal microstructural changes in diabetic macular edema. Retina 30:774–780
26. Shin HJ, Lee SH, Chung H, Kim HC (2012) Association between photoreceptor integrity and visual outcome in diabetic macular edema. Graefes Arch Clin Exp Ophthalmol 250:61–70
27. ®. Eur J Ophthalmol 21:631–636
28. Shin HJ, Chung H, Kim HC (2011) Association between integrity of foveal photoreceptor layer and visual outcome in retinal vein occlusion. Acta Ophthalmol 89:35–40
29. Ota M, Tsujikawa A, Murakami T, Yamaike N, Sakamoto A, Kotera Y et al (2008) Foveal photoreceptor in eyes with persistent cystoid macular edema associated with branch retinal vein occlusion. Am J Ophthalmol 145:273–280
30. Ianetti L, Spinucci G, Abbouda A, De Geronimo D, Tortorella D, Accorinti M (2012) Spectral domain optical coherence tomography in uveitic macular edema: morphological features and prognostic factors. Ophthalmologica 228:13–18
31. ® assessment for diabetic macular edema: MOZART study. J Fr Ophtalmol 37:480–485
32. Boyer DS, Yoon YH, Belfort R Jr, Bandello F, Maturi RK, Augustin AJ et al (2014) Ozurdex MEAD study group. Three-year, randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with diabetic macular edema. Ophthalmology 121:1904–1914
33. Gillies MC, Lim LL, Campain A, Quin GJ, Salem W, Li J et al (2014) A randomized clinical trial of intravitreal bevacizumab versus intravitreal dexamethasone for diabetic macular edema: the BEVORDEX study. Ophthalmology 121:2473–2481